Y2X Prostate plus
Natural health product licensed in Canada
- Other names
- Cyctek Prostate plus Capsule, Y2X Prostate ultra, Y2X Ultra Prostate Tonic, Y2X Ultra Prostatic Health capsule
- Licence holder
- CycTek Inc.
- NPN or DIN-HM
- 80073573
- Status
- Active licence
- Licence date
- 4 November 2016
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Serenoa repens (W.Bartram) Small: L'étiquetage doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Commiphora myrrha Source : Stem resin | 86.77 milligramme | Not calculated |
| Angelica dahurica Source : Racine | 86.77 milligramme | Not calculated |
| Serenoa repens Source : Fruit Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 200 milligramme | 50 milligramme | Not calculated |
| Patrinia scabiosifolia Source : Sommité Extract : Matériel brut sec Extraction ratio : 7.062:1 Dry plant equivalent : 156.5 milligramme | 22.16 milligramme | Not calculated |
| Paeonia lactiflora Source : Racine Extract : Matériel brut sec Extraction ratio : 7.062:1 Dry plant equivalent : 94 milligramme | 13.31 milligramme | Not calculated |
| Prunus persica Source : Graine(s) Extract : Matériel brut sec Extraction ratio : 7.062:1 Dry plant equivalent : 94 milligramme | 13.31 milligramme | Not calculated |
| Salvia miltiorrhiza Source : Racine et rhizome Extract : Matériel brut sec Extraction ratio : 7.062:1 Dry plant equivalent : 94 milligramme | 13.31 milligramme | Not calculated |
| Carthamus tinctorius Source : Fleur Extract : Matériel brut sec Extraction ratio : 7.062:1 Dry plant equivalent : 94 milligramme | 13.31 milligramme | Not calculated |
| Vaccaria hispanica subsp. hispanica Source : Graine(s) Extract : Matériel brut sec Extraction ratio : 7.062:1 Dry plant equivalent : 156.5 milligramme | 22.16 milligramme | Not calculated |
| Melia azedarach Source : Fruit Extract : Matériel brut sec Extraction ratio : 7.062:1 Dry plant equivalent : 156.5 milligramme | 22.16 milligramme | Not calculated |
| Pyrrosia lingua Source : Feuille Extract : Matériel brut sec Extraction ratio : 7.062:1 Dry plant equivalent : 94 milligramme | 13.31 milligramme | Not calculated |
| Lycopus lucidus var. hirtus Source : Sommité Extract : Matériel brut sec Extraction ratio : 7.062:1 Dry plant equivalent : 94 milligramme | 13.31 milligramme | Not calculated |
| Gleditsia sinensis Source : Épine | 144.65 milligramme | Not calculated |
| Taraxacum mongolicum Source : Sommité en fleurs (herbe) Extract : Matériel brut sec Extraction ratio : 7.062:1 Dry plant equivalent : 156.5 milligramme | 22.16 milligramme | Not calculated |
| Lycium barbarum Source : Fruit Extract : Matériel brut sec Extraction ratio : 7.062:1 Dry plant equivalent : 94 milligramme | 13.31 milligramme | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Cellulose, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 4 Capsule | 2 Tous les jours |
Uses authorised in Canada
Used in Herbal Medicine to help relieve the urologic symptoms (e.g. weak urine flow, incomplete voiding, pain, frequent daytime and night time urination) associated with mild to moderate benign prostatic hyperplasia.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
If symptoms persist or worsen, or if new symptoms develop, discontinue use and consult a health care practitioner. Keep out of reach of children. Consult a health care practitioner prior to use to exclude a diagnosis of prostate cancer. Do not use if you have liver or kidney disorders.
Source
Official Health Canada record, licence 80073573
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.